These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38465977)

  • 1. 68 Ga-DOTA-Ibandronic Acid PET/CT in a Patient With Chemotherapy-Induced Salivary Gland Hypofunction.
    Liu Y; Ding H; Zhang T; Chen Y; Huang Z
    Clin Nucl Med; 2024 May; 49(5):470-471. PubMed ID: 38465977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 68 Ga-DOTA-IBA Uptake in Breast cancer.
    Xiang F; Liu H; Tan X; Chen Y
    Clin Nucl Med; 2024 Jun; 49(6):574-575. PubMed ID: 38537211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of 68 Ga- or 177 Lu-Labeled DOTA-IBA as a Novel Theranostic Radiopharmaceutical for Bone Metastases : A Phase 0/I Study.
    Qiu L; Wang Y; Liu H; Wang Q; Chen L; Liu L; Wang L; Feng Y; Chen Y
    Clin Nucl Med; 2023 Jun; 48(6):489-496. PubMed ID: 36976706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary results of biodistribution and dosimetric analysis of [
    Khawar A; Eppard E; Roesch F; Ahmadzadehfar H; Kürpig S; Meisenheimer M; Gaertner FC; Essler M; Bundschuh RA
    Ann Nucl Med; 2019 Jun; 33(6):404-413. PubMed ID: 30877560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lutetium177-Labeled DOTA-Ibandronate: A Novel Radiopharmaceutical for Targeted Treatment of Bone Metastases.
    Wang Q; Yang J; Wang Y; Liu H; Feng Y; Qiu L; Chen Y
    Mol Pharm; 2023 Mar; 20(3):1788-1795. PubMed ID: 36802692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective comparison of
    Xiang F; Zhang Y; Tan X; Yan Y; Liu H; Ma W; Chen Y
    Front Oncol; 2024; 14():1428498. PubMed ID: 39144828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vertebral metastases from neuroendocrine tumours: How to avoid false positives on
    Gauthé M; Testart Dardel N; Ruiz Santiago F; Ohnona J; Nataf V; Montravers F; Talbot JN
    Eur Radiol; 2018 Sep; 28(9):3943-3952. PubMed ID: 29532242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary experience with (68)Ga-DOTA-lanreotide positron emission tomography.
    Traub-Weidinger T; Von Guggenberg E; Dobrozemsky G; Kendler D; Eisterer W; Bale R; Putzer D; Gabriel M; Virgolini I
    Q J Nucl Med Mol Imaging; 2010 Feb; 54(1):52-60. PubMed ID: 20168286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased uptake of
    Qin C; Song Y; Liu X; Gai Y; Liu Q; Ruan W; Liu F; Hu F; Lan X
    Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):709-720. PubMed ID: 34241652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodistribution and Internal Dosimetry of 68 Ga-DOTA-IBA PET Imaging for Patients With Bone Metastases.
    Yang J; Deng J; Fan D; Chen G; Lu Z; Liu H; Mok GSP; Chen Y
    Clin Nucl Med; 2023 Oct; 48(10):847-852. PubMed ID: 37418288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [
    Lin R; Lin Z; Chen Z; Zheng S; Zhang J; Zang J; Miao W
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2960-2971. PubMed ID: 35462566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodistribution, pharmacokinetics, dosimetry of [
    Ballal S; Yadav MP; Moon ES; Kramer VS; Roesch F; Kumari S; Tripathi M; ArunRaj ST; Sarswat S; Bal C
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1915-1931. PubMed ID: 33244617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Intestinal Inflammation by Vascular Adhesion Protein-1-Targeted [
    Bhowmik AA; Heikkilä TRH; Polari L; Virta J; Liljenbäck H; Moisio O; Li XG; Viitanen R; Jalkanen S; Koffert J; Toivola DM; Roivainen A
    Mol Imaging Biol; 2024 Apr; 26(2):322-333. PubMed ID: 38110791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical prospective study of Gallium 68 (
    Jinghua L; Kui X; Deliang G; Bo L; Qian Z; Haitao W; Yaqun J; Dongde W; Xigang X; Ping J; Shengli T; Zhiyong Y; Yueming H; Zhonglin Z; Yong H; Yufeng Y
    Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):2152-2166. PubMed ID: 36809426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential utility of [
    Li Y; Deng L; Feng Y; Liu L; Lv F; Qiu L
    Eur Radiol; 2023 Dec; 33(12):9378-9389. PubMed ID: 37454338
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Chen Y; Zheng S; Zhang J; Yao S; Miao W
    Ann Nucl Med; 2022 Jul; 36(7):610-622. PubMed ID: 35551610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential utility of [
    Lan L; Liu H; Wang Y; Deng J; Peng D; Feng Y; Wang L; Chen Y; Qiu L
    Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):963-979. PubMed ID: 34410435
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Parihar AS; Mittal BR; Kumar R; Shukla J; Bhattacharya A
    Thyroid; 2020 Apr; 30(4):557-567. PubMed ID: 31870227
    [No Abstract]   [Full Text] [Related]  

  • 20. The diagnostic accuracy of
    Daniels H; Gilbert R; Bonin L
    J Med Imaging Radiat Sci; 2023 Sep; 54(3):545-555. PubMed ID: 37211439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.